...
首页> 外文期刊>Journal of Nippon Medical School >Case Report: 84-Month Disease-Free Survival after Surgery for Anaplastic Thyroid Carcinoma
【24h】

Case Report: 84-Month Disease-Free Survival after Surgery for Anaplastic Thyroid Carcinoma

机译:病例报告:间变性甲状腺癌手术后84个月无病生存

获取原文
           

摘要

We present a rare case of a patient with anaplastic thyroid carcinoma (ATC) who survived for 87 months after surgery. The patient was a 71-year-old man who presented with a painful enlarged mass in the right side of his neck that rapidly enlarged over 2 months. He was diagnosed with T4a, stage IVA ATC with no distant metastasis and underwent total thyroidectomy with modified neck dissection. Although only radiation and radioactive iodine therapy were administered after surgery, he remained disease-free for 84 months. Bone metastasis occurred after 84 months, and he was treated with Lenvatinib, but he died from a decline in his general condition 3 months later. We suggest that surgery is effective for stage IVA ATC, but adjuvant therapy is necessary for long-term disease-free survival in this patient population.
机译:我们介绍了罕见的间变性甲状腺癌(ATC)患者在手术后存活87个月的病例。该患者是一名71岁的男子,颈部右侧肿块肿痛,并在2个月内迅速肿大。他被诊断出患有T4a,IVA ATC分期,没有远处转移,并且接受了全甲状腺切除术并改良了颈部夹层。尽管手术后仅进行了放射疗法和放射性碘疗法,但他仍然无病84个月。 84个月后发生骨转移,他接受了Lenvatinib治疗,但死于3个月后总体状况下降。我们建议手术对IVA ATC分期有效,但辅助治疗对于该患者人群的长期无病生存是必需的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号